Washio M, Inoue N
Department of Public Health, Faculty of Medicine, Kyushu University, Fukuoka.
Fukuoka Igaku Zasshi. 1997 Nov;88(11):352-7.
Since adverse effects rarely occur with the therapeutic doses of acetaminophen, it is commonly used as a mild antipyletic and analgesic. However, overdosage of acetaminophen causes fatal hepatic failure and acute renal failure. Therefore, we evaluated the risk factors for death among the reported cases of acetaminophen poisoning in Japan, which were obtained from Japan Science and Technology Corporation, Information Center for Science and Technology (JICST) on-line service in the Kyushu University Library. In a univariate analysis, the death rate of patients with hepatic failure (23.3% vs 0%, p = 0.04), disseminated intravascular coagulation syndrome (DIC) (38.1% vs 5.3%, p = 0.001) or plasma exchange treatment (33.3% vs 7.9%, p = 0.01) was significantly greater than those without it while a multivariate analysis revealed that DIC (with vs without; odds ratio = 23.04, 95% confidence interval = 2.80-189.75) and the treatment with plasma exchange (with vs without; odds ratio = 14.77, 95% confidence interval = 1.44-151.52) were independent risk factors. These results suggest that DIC and hepatic failure, especially requiring plasma exchange, were poor prognostic factors. In addition, about seventeen percent of the cases with less than 5 g of acetaminophen ingestion were death cases although the acute lethal adult dose is shown 13-25 g in western countries. This suggests that its acute lethal dose may be low in Japan, which may be partly due to the additional adverse effect of other drugs used in the mixed compounds while acetaminophen alone is used in western countries. An intensive treatment should be recommended for the acetaminophen poisoning patients regardless of the ingested dose.
由于对乙酰氨基酚治疗剂量很少产生不良反应,它通常被用作轻度退烧药和镇痛药。然而,对乙酰氨基酚过量会导致致命的肝衰竭和急性肾衰竭。因此,我们评估了日本报道的对乙酰氨基酚中毒病例的死亡风险因素,这些病例来自日本科学技术公司、九州大学图书馆的科学技术信息中心(JICST)在线服务。单因素分析显示,肝衰竭患者(23.3%对0%,p = 0.04)、弥散性血管内凝血综合征(DIC)患者(38.1%对5.3%,p = 0.001)或接受血浆置换治疗的患者(33.3%对7.9%,p = 0.01)的死亡率显著高于未出现这些情况的患者,而多因素分析显示,DIC(有vs无;比值比 = 23.04,95%置信区间 = 2.80 - 189.75)和血浆置换治疗(有vs无;比值比 = 14.77,95%置信区间 = 1.44 - 151.52)是独立的风险因素。这些结果表明,DIC和肝衰竭,尤其是需要进行血浆置换的情况,是预后不良的因素。此外,尽管西方国家显示对乙酰氨基酚的急性致死成人剂量为13 - 25 g,但摄入对乙酰氨基酚少于5 g的病例中约17%为死亡病例。这表明在日本其急性致死剂量可能较低,这可能部分归因于混合制剂中使用的其他药物的额外不良反应,而西方国家单独使用对乙酰氨基酚。无论摄入剂量如何,对对乙酰氨基酚中毒患者均应推荐强化治疗。